Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats

European Neuropsychopharmacology

Volumn 25, Issue 12, 2015, Pages 2404-2415

  Zamberletti, Erica ^a,b   Gabaglio, Marina ^a   Prini, Pamela ^a   Rubino, Tiziana ^a   Parolaro, Daniela ^a,b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b Zardi Gori Foundation   (Italy)

Author keywords

Adolescence; Cognition; Neuroinflammation; Prefrontal cortex; Rats; THC

Indexed keywords

BIOLOGICAL MARKER; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CYCLOOXYGENASE 2; DRONABINOL; IBUDILAST; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; PHOSPHODIESTERASE INHIBITOR; PSYCHEDELIC AGENT; PYRIDINE DERIVATIVE;

ADOLESCENCE; ADULT; ADULTHOOD; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CANNABIS USE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; FEMALE; HIPPOCAMPUS; MEMORY DISORDER; MICROGLIA; MOOD; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SHORT TERM MEMORY; AGE; ANIMAL; CHEMICALLY INDUCED; COGNITION DISORDERS; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; ENCEPHALITIS; GENE EXPRESSION REGULATION; HUMAN RELATION; METABOLISM; NEWBORN; PATHOLOGY; PSYCHOLOGY; RECOGNITION; SPRAGUE DAWLEY RAT; SWIMMING; TONIC IMMOBILITY;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; COGNITION DISORDERS; CYCLOOXYGENASE 2; CYTOKINES; DISEASE MODELS, ANIMAL; DRONABINOL; ENCEPHALITIS; FEMALE; GENE EXPRESSION REGULATION; HALLUCINOGENS; IMMOBILITY RESPONSE, TONIC; INTERPERSONAL RELATIONS; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHODIESTERASE INHIBITORS; PREFRONTAL CORTEX; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECOGNITION (PSYCHOLOGY); SWIMMING;

EID: 84952636533     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.09.021     Document Type: Article

References (36)

1. Andersen S.L. Trajectories of brain development: point of vulnerability or window of opportunity?. Neurosci. Biobehav. Rev. 2003, 27:3-18.
2. Chambers R.A., Taylor J.R., Potenza M.N. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am. J. Psychiatry 2003, 160:1041-1052.
3. Chang J.Y., Chavis J.A., Liu L.Z., Drew P.D. Cholesterol oxides induce programmed cell death in microglial cells. Biochem. Biophys. Res. Commun. 1998, 249:817-821.
4. Cutando L., Busquets-Garcia A., Puighermanal E., Gomis-González M., Delgado-García J.M., Gruart A., Maldonado R., Ozaita A. Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure. J. Clin. Invest. 2013, 123:2816-2831.
5. Fernández-Ruiz J., Moreno-Martet M., Rodríguez-Cueto C., Palomo-Garo C., Gómez-Cañas M., Valdeolivas S., Guaza C., Romero J., Guzmán M., Mechoulam R., Ramos J.A. Prospects for cannabinoid therapies in basal ganglia disorders. Br. J. Pharmacol. 2011, 163:1365-1378.
6. Ferretjans R., de Campos S.M., Ribeiro-Santos R., Guimarães F.C., de Oliveira K., Cardoso A.C., Araújo M.S., Teixeira-Carvalho A., Martins-Filho O.A., Teixeira A.L., Salgado.J.V. Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia. Schizophr. Res. 2014, 156:254-260.
7. Frick L.R., Williams K., Pittenger C. Microglial dysregulation in psychiatric disease. Clin. Dev. Immunol. 2013, 608654.
8. Gibson L.C., Hastings S.F., McPhee I., Clayton R.A., Darroch C.E., Mackenzie A., Mackenzie F.L., Nagasawa M., Stevens P.A., Mackenzie S.J. The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family. Eur. J. Pharmacol. 2006, 538:39-42.
9. Giedd J.N., Blumenthal J., Jeffries N.O., Castellanos F.X., Liu H., Zijdenbos A., Paus T., Evans A.C., Rapoport J.L. Brain development during childhood and adolescence: a longitudinal MRI study. Nat. Neurosci. 1999, 2:861-863.
10. Johnston, L.D., O'Malley, P.M., Bachman, J.G., Schulenberg, J.E., Monitoring the Future: national results on adolescent drug use: Overview of key findings, 2011, 2012, Ann Arbor: Institute for Social Research, The University of Michigan.
11. Klein T.W. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat. Rev. Immunol. 2005, 5:400-411.
12. Kobayashi K., Imagama S., Ohgomori T., Hirano K., Uchimura K., Sakamoto K., Hirakawa A., Takeuchi H., Suzumura A., Ishiguro N., Kadomatsu K. Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis. 2013, 4:e525.
13. Liu W., Tang Y., Feng J. Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system. Life Sci. 2011, 89:141-146.
14. Lombard C., Hegde V.L., Nagarkatti M., Nagarkatti P.S. Perinatal exposure to δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens. J. Pharmacol. Exp. Ther. 2011, 339:607-617.
15. Lyman M., Lloyd D.G., Ji X., Vizcaychipi M.P., Ma D. Neuroinflammation: the role and consequences. Neurosci. Res. 2014, 79:1-12.
16. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology 2002, 159:379-387.
17. Molina-Holgado E., Vela J.M., Arévalo-Martin A., Almazán G., Molina-Holgado F., Borrell J., Guaza C. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptor and phosphatidyllinositol-3 kinase/Akt signaling. J. Neurosci. 2002, 22:9742-9753.
18. 9-Tetrahydrocannabinol-induced anti-inflammatory responses in adolescent mice switch to proinflammatory in adulthood. J. Leukoc. Biol. 2014, 96:523-534.
19. Najjar S., Pearlman D.M., Alper K., Najjar A., Devinsky O. Neuroinflammation and psychiatric illness. J. Neuroinflamm. 2013, 10:43.
20. Paolicelli R.C., Gross C.T. Microglia in development: linking brain wiring to brain environment. Neuron Glia Biol. 2011, 7:77-83.
21. Realini N., Vigano' D., Guidali C., Zamberletti E., Rubino T., Parolaro D. Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. Neuropharmacology 2011, 60:235-243.
22. Renard J., Krebs M.O., Le Pen G., Jay T.M. Long-term consequences of adolescent cannabinoid exposure in adult psychopathology. Front. Neurosci. 2014, 8:361.
23. Rubino T., Parolaro D. Sex-dependent vulnerability to Cannabis abuse in adolescence. Front. Psychiatry 2015, 6:56.
24. Rubino T., Prini P., Piscitelli F., Zamberletti E., Trusel M., Melis M., Sagheddu C., Ligresti A., Tonini R., Di Marzo V., Parolaro D. Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex. Neurobiol. Dis. 2015, 73:60-69.
25. Rubino T., Realini N., Braida D., Alberio T., Capurro V., Viganò D., Guidali C., Sala M., Fasano M., Parolaro D. The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex. Neurotox. Res. 2009, 15:291-302.
26. Rubino T., Vigano' D., Realini N., Guidali C., Braida D., Capurro V., Castiglioni C., Cherubino F., Romualdi P., Candeletti S., Sala M., Parolaro D. Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology 2008, 33:2760-2771.
27. Schafer D.P., Lehrman E.K., Stevens B. The "quad-partite" synapse: microglia-synapse interactions in the developing and mature CNS. Glia 2013, 61:24-36.
28. Schubert P., Morino T., Miyazaki H., Ogata T., Nakamura Y., Marchini C., Ferroni S. Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. Ann. N. Y. Acad. Sci. 2000, 903:24-33.
29. Sowell E.R., Thompson P.M., Holmes C.J., Jernigan T.L., Toga A.W. In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat. Neurosci. 1999, 2:859-861.
30. Sowell E.R., Thompson P.M., Tessner K.D., Toga A.W. Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: Inverse relationships during postadolescent brain maturation. J. Neurosci. 2001, 21:8819-8829.
31. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 2000, 24:417-463.
32. Steiner M.A., Wanisch K., Monory K., Marsicano G., Borroni E., Bächli H., Holsboer F., Lutz B., Wotjak C.T. Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. Pharmacogenom. J. 2008, 8:196-208.
33. Stella N. Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 2010, 58:1017-1030.
34. Tremblay M.È. The role of microglia at synapses in the healthy CNS: novel insights from recent imaging studies. Neuron Glia Biol. 2011, 7:67-76.
35. Walter L., Stella N. Cannabinoids and neuroinflammation. Br. J. Pharmacol. 2004, 141:775-785.
36. Zamberletti E., Beggiato S., Steardo L., Prini P., Antonelli T., Ferraro L., Rubino T., Parolaro D. Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats. Neurobiol. Dis. 2014, 63:35-47.